PMID- 38017286 OWN - NLM STAT- Publisher LR - 20231128 IS - 1573-4927 (Electronic) IS - 0006-2928 (Linking) DP - 2023 Nov 29 TI - Extracellular Vesicles from Human Adipose Tissue-Derived Mesenchymal Stem Cells Suppress RANKL-Induced Osteoclast Differentiation via miR122-5p. LID - 10.1007/s10528-023-10569-5 [doi] AB - Researchers are increasingly interested in cell therapy using mesenchymal stem cells (MSCs) as an alternative remedy for osteoporosis, with fewer side effects. Thus, we isolated and characterized extracellular vesicles (EVs) from human adipose tissue-derived MSCs (hMSCs) and investigated their inhibitory effects on RANKL-induced osteoclast differentiation. Purified EVs were collected from the supernatant of hMSCs by tangential flow filtration. Characterization of EVs included typical evaluation of the size and concentration of EVs by nanoparticle tracking analysis and morphology analysis using transmission electron microscopy. hMSC-EVs inhibited RANKL-induced differentiation of bone marrow-derived macrophages (BMDMs) into osteoclasts in a dose-dependent manner. F-actin ring formation and bone resorption were also reduced by EV treatment of osteoclasts. In addition, EVs decreased RANKL-induced phosphorylation of p38 and JNK and expression of osteoclastogenesis-related genes in BMDMs treated with RANKL. To elucidate which part of the hMSC-EVs plays a role in the inhibition of osteoclast differentiation, we analyzed miRNA profiles in hMSC-EVs. The results showed that has-miR122-5p was present at significantly high read counts. Overexpression of miR122-5p in BMDMs significantly inhibited RANKL-induced osteoclast differentiation and induced defects in F-actin ring formation and bone resorption. Our results also revealed that RANKL-induced phosphorylation of p38 and JNK and osteoclast-specific gene expression was decreased by miR122-5p transfection, which was consistent with the results of hMSC-EVs. These findings suggest that hMSC-EVs containing miR122-5p inhibit RANKL-induced osteoclast differentiation via the downregulation of molecular mechanisms and could be a preventive candidate for destructive bone diseases. CI - (c) 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. FAU - Choi, Joo-Hee AU - Choi JH AD - Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, 41061, Republic of Korea. FAU - Sung, Soo-Eun AU - Sung SE AD - Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, 41061, Republic of Korea. FAU - Kang, Kyung-Ku AU - Kang KK AD - Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, 41061, Republic of Korea. FAU - Lee, Sijoon AU - Lee S AD - Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, 41061, Republic of Korea. FAU - Sung, Minkyoung AU - Sung M AD - Laboratory Animal Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, 41061, Republic of Korea. FAU - Park, Wook-Tae AU - Park WT AD - Department of Orthopedic Surgery, Yeungnam University College of Medicine, Yeungnam University Medical Center, 170 Hyonchung-ro, Namgu, Daegu, 42415, Republic of Korea. FAU - Kim, Young In AU - Kim YI AD - Cellexobio, Co., Ltd., Daegu, 42415, Korea. FAU - Seo, Min-Soo AU - Seo MS AD - Department of Veterinary Tissue Engineering, Laboratory of Veterinary Tissue Engineering, College of Veterinary Medicine, Kyungpook National University, 80 Daehak-ro, Buk-gu, Daegu, 41566, Republic of Korea. msseo@knu.ac.kr. FAU - Lee, Gun Woo AU - Lee GW AD - Department of Orthopedic Surgery, Yeungnam University College of Medicine, Yeungnam University Medical Center, 170 Hyonchung-ro, Namgu, Daegu, 42415, Republic of Korea. gwlee1871@gmail.com. LA - eng GR - 2020R1F1A1072045/National Research Foundation of Korea/ GR - 2022R1C1C1005410/National Research Foundation of Korea/ GR - RS-2023-00219725/Regional Leading Research Center of Korea/ PT - Journal Article DEP - 20231129 PL - United States TA - Biochem Genet JT - Biochemical genetics JID - 0126611 SB - IM OTO - NOTNLM OT - Extracellular vesicles OT - Mesenchymal stem cells OT - Osteoclast OT - miR122-5p EDAT- 2023/11/29 00:42 MHDA- 2023/11/29 00:42 CRDT- 2023/11/28 23:51 PHST- 2023/05/02 00:00 [received] PHST- 2023/10/26 00:00 [accepted] PHST- 2023/11/29 00:42 [medline] PHST- 2023/11/29 00:42 [pubmed] PHST- 2023/11/28 23:51 [entrez] AID - 10.1007/s10528-023-10569-5 [pii] AID - 10.1007/s10528-023-10569-5 [doi] PST - aheadofprint SO - Biochem Genet. 2023 Nov 29. doi: 10.1007/s10528-023-10569-5.